🇺🇸 FDA
Patent

US 10272163

Factor VIII mutation repair and tolerance induction

granted A61KA61K38/00A61K48/0066

Quick answer

US patent 10272163 (Factor VIII mutation repair and tolerance induction) held by THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Grant date
Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K48/0066